MediPoint: Rheumatoid Arthritis Testing - Global Analysis and Market Forecasts
"MediPoint:
Rheumatoid Arthritis Testing - Global Analysis and Market Forecasts".
The Report covers current Market Trends, Analysis, Forecast, Review,
Share, Size, Growth, Effect.
Description-
Summary
Rheumatoid
Arthritis
(RA) is the commonest autoimmune disease in humans. The disease is
prevalent in all ethnic groups, affecting approximately 1.0% of the
world population. Presently there is a huge presence of unmet patient
needs for both the treatment and diagnosis.
Focus
for the treatment paradigm has now shifted towards the early
detection and diagnosis of the disease, which will allow physicians
to begin aggressive treatment of the condition, minimizing the
associated complications and tissue damage.
Global
sales of $347m in 2016 and estimated growth rate of 2% during the
forecast period; the emerging markets: Brazil, Canada, China and
Mexico are expected to show the fastest growth.
Key
market drivers -
-
Increasing prevalence of autoimmune diseases globally including RA
-
Emerging biomarkers and advancement in technology for the early
diagnosis of RA
-
Increasing adoption of anti-cyclic citrullinated peptide (anti-CCP)
antibody test
-
Rising demand for lab automation
Key
market barriers -
-
Limited sensitivity of existing RA diagnostic tests
-
Healthcare cost-cutting and reduced reimbursement in major markets
Highlights
Key
Questions Answered
-
What is the current and future RA testing market outlook in the
developed and emerging markets? What trends are affecting the global
market?
-
What is the competitive landscape and who are major players in the RA
testing space?
-
What are the key, high growth markets that IVD manufacturers should
expand into? Which market segments are growing the fastest?
-
What are the unmet needs with the RA tests currently on the market?
How will emerging technologies such as POC assays fulfil these unmet
needs?
-
What are the key products and pipelines in the RA testing market?
-
What are the challenges and barriers that have hindered widespread
adoption of RA tests in different regions?
Scope
-
Competitive assessment: Currently marketed RA diagnostic products and
evolving competitive landscape
-
In-depth analysis of unmet needs and adoption trends of different RA
diagnostic tests
-
Insightful review of the key industry drivers, opportunities,
restraints and challenges. Each trend is independently researched to
provide qualitative analysis of its implications
-
Pipeline analysis: Emerging products and technologies.
-
Annualized total RA testing market revenue by segment and market
outlooks by country from 2013-2022.
-
Other key topics covered include strategic competitive assessment,
market characterization, identification of unmet needs, market
dynamics, and implications of the emerging technologies on the
market.
For
More Information Kindly Contact:
ResearchMoz
Global Pvt. Ltd.
90
State Street,
Albany,
NY 12207,
United
States
Blog
- http://bit.ly/2b1Ayn6
866-997-4948
(Us-Canada Toll Free),
+1-518-621-2074,
Email
to:
sales@researchmoz.us,
Comments
Post a Comment